Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
Ridhima Kaul, Pradipta Paul, Sanjay Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11069-11069
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19
Qing Hu, Yuan Xiong, Guanghao Zhu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 138
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 50
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
Otávio Augusto Chaves, Natália Fintelman-Rodrigues, Xuanting Wang, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1458-1458
Open Access | Times Cited: 37
Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Inhibitory Efficacy of Main Components of Scutellaria baicalensis on the Interaction between Spike Protein of SARS-CoV-2 and Human Angiotensin-Converting Enzyme II
Cheng‐Han Lin, Ho-Ju Chang, M. C. Lin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2935-2935
Open Access | Times Cited: 7
Multi-therapeutic potential of flavonoids as an essential component in nutraceuticals for the treatment and management of human diseases
Stanley I.R. Okoduwa, Ibrahim Abdulwaliyu, Bernard E. Igiri, et al.
Phytomedicine Plus (2024) Vol. 4, Iss. 2, pp. 100558-100558
Open Access | Times Cited: 7
Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Foods (2022) Vol. 11, Iss. 18, pp. 2884-2884
Open Access | Times Cited: 34
A multi-targeted approach to identify potential flavonoids against three targets in the SARS-CoV-2 life cycle
Sanjay Kumar, Pradipta Paul, Pardeep Yadav, et al.
Computers in Biology and Medicine (2022) Vol. 142, pp. 105231-105231
Open Access | Times Cited: 33
The Mechanism of a Retro-Diels–Alder Fragmentation of Luteolin: Theoretical Studies Supported by Electrospray Ionization Tandem Mass Spectrometry Results
Magdalena Śliwka‐Kaszyńska, Iwona Anusiewicz, Piotr Skurski
Molecules (2022) Vol. 27, Iss. 3, pp. 1032-1032
Open Access | Times Cited: 32
Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases
Otávio Augusto Chaves, Carlyle Ribeiro Lima, Natália Fintelman-Rodrigues, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 1015-1026
Open Access | Times Cited: 28
A strategy for evaluating potential antiviral resistance to small molecule drugs and application to SARS-CoV-2
Karen Sargsyan, Karine Mazmanian, Carmay Lim
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Chemical Compositions of Scutellaria baicalensis Georgi. (Huangqin) Extracts and Their Effects on ACE2 Binding of SARS-CoV-2 Spike Protein, ACE2 Activity, and Free Radicals
Boyan Gao, Hanshu Zhu, Zhihao Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2045-2045
Open Access | Times Cited: 4
Exploiting the potential of natural polyphenols as antivirals against monkeypox envelope protein F13 using machine learning and all-atoms MD simulations
Madhusmita Rout, Sarbani Mishra, Suchanda Dey, et al.
Computers in Biology and Medicine (2023) Vol. 162, pp. 107116-107116
Open Access | Times Cited: 13
Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models
Jooeun Lee, Se Yun Jeong, Zijun Li, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 11
Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication
Guilherme S. Caleffi, Alice dos Santos Rosa, Luana G. de Souza, et al.
Journal of Natural Products (2023) Vol. 86, Iss. 6, pp. 1536-1549
Closed Access | Times Cited: 11
An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes
Anns Mahboob, Degiri Kalana Lasanga Senevirathne, Pradipta Paul, et al.
International Journal of Biological Macromolecules (2022) Vol. 225, pp. 318-350
Open Access | Times Cited: 19
Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases
Biswanath Dinda, Subhajit Dinda, Manikarna Dinda
Phytomedicine Plus (2022) Vol. 3, Iss. 1, pp. 100402-100402
Open Access | Times Cited: 19
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity
Mattia Mori, Deborah Quaglio, Andrea Calcaterra, et al.
Microorganisms (2023) Vol. 11, Iss. 2, pp. 314-314
Open Access | Times Cited: 9
Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-O-(6″-O-acetyl)-Glucoside from Calligonum tetrapterum
E. M. Suleimen, Rani Alphonsa Jose, G. К. Mamytbekova, et al.
Plants (2022) Vol. 11, Iss. 15, pp. 2072-2072
Open Access | Times Cited: 17
The Promising Role of Microbiome Therapy on Biomarkers of Inflammation and Oxidative Stress in Type 2 Diabetes: A Systematic and Narrative Review
Pradipta Paul, Ridhima Kaul, Basma Abdellatif, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 15
Antiviral and Possible Prophylactic Significance of Myricetin for COVID-19
Pawan K. Agrawal, Chandan Agrawal, Gerald Blunden
Natural Product Communications (2023) Vol. 18, Iss. 4
Open Access | Times Cited: 8
Myrtucommulones and Related Acylphloroglucinols from Myrtaceae as a Promising Source of Multitarget SARS-CoV-2 Cycle Inhibitors
Simony Carvalho Mendonça, Brendo Araújo Gomes, Mariana Freire Campos, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 436-436
Open Access | Times Cited: 2
Influence of EGCG oxidation on inhibitory activity against the SARS-CoV-2 main protease
Yufeng He, Meng Hao, Mingchuan Yang, et al.
International Journal of Biological Macromolecules (2024) Vol. 274, pp. 133451-133451
Closed Access | Times Cited: 2
The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus
Shaza S. Issa, С. В. Сокорнова, Roman R. Zhidkin, et al.
Plants (2022) Vol. 11, Iss. 14, pp. 1862-1862
Open Access | Times Cited: 14
Artecanin of Laurus nobilis is a novel inhibitor of SARS-CoV-2 main protease with highly desirable druglikeness
Mohammed Baqur S. Al‐Shuhaib, Hayder O. Hashim, Jafar M. B. Al‐Shuhaib, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 6, pp. 2355-2367
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top